Telmisartan vs. Valsartan in Patients With Mild to Moderate Hypertension Following a Missed Dose

ClinicalTrials.gov ID: NCT00034840

Public ClinicalTrials.gov record NCT00034840. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Jul 23, 2026, 2:09 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Prospective, Randomized, Double-Blind, Forced Titration Trial to Compare the Efficacy of MICARDIS® (Telmisartan 80 mg p.o. Once Daily) and Diovan® (Valsartan 160 mg p.o. Once Daily) Using Ambulatory Blood Pressure Monitoring (ABPM) in Patients With Mild to Moderate Hypertension After Missing One Dose

Study identification

NCT ID: NCT00034840
Recruitment status: Completed
Study type: Interventional
Phase: Phase 4
Lead sponsor: Boehringer Ingelheim; Industry
Enrollment: 490 participants

Conditions and interventions

Conditions

Hypertension

Interventions

telmisartan, valsartan Drug

Drug

Eligibility (public fields only)

Age range: 18 Years and older
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Sep 30, 2001
Primary completion: Jul 31, 2002
Completion: Jul 31, 2002
Last update posted: Oct 31, 2013

2001 – 2002

United States locations

U.S. sites: 16
U.S. states: 12
U.S. cities: 15

Facility	City	State	ZIP	Site status
Memorial Research Medical Clinic	Long Beach	California	90806	—
National Research Institute	Los Angeles	California	90057	—
Orange County Research Center	Orange	California	92868	—
University of Conn. Health Services Center, Hypertension and Vascular Disease	Farmington	Connecticut	06030	—
Alan Graff	Fort Lauderdale	Florida	33308	—
Greater Ft. Lauderdale Heart Group Research	Fort Lauderdale	Florida	33308	—
Orlando Clinical Research Center	Orlando	Florida	32806	—
So. Clinical Research and Management, Inc.	Augusta	Georgia	30904	—
Rush Presbyterian/St. Luke's Medical Center	Chicago	Illinois	60612	—
University of Maryland/Nephrology Clinical Research Unit	Baltimore	Maryland	21201	—
Washington University	St Louis	Missouri	63110	—
Oklahoma Cardiovascular and Hypertension Center	Oklahoma City	Oklahoma	73132	—
Michael A. Azorr, M.D.	Portland	Oregon	97232	—
Harleysville Medical Associates	Harleysville	Pennsylvania	19438	—
Trinity Hypertension Research Institute/Punzi Medical Center	Carrollton	Texas	75006	—
UW Health/Physicians Plus Center for Clinical Trials	Madison	Wisconsin	53715	—

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 19 non-U.S. sites.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT00034840, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Oct 31, 2013 · Synced Jul 23, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00034840 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →